209 related articles for article (PubMed ID: 20699437)
21. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
22. Androgen receptor is causally involved in the homeostasis of the human prostate endothelial cell.
Godoy A; Watts A; Sotomayor P; Montecinos VP; Huss WJ; Onate SA; Smith GJ
Endocrinology; 2008 Jun; 149(6):2959-69. PubMed ID: 18292195
[TBL] [Abstract][Full Text] [Related]
23. CL1-GFP: an androgen independent metastatic tumor model for prostate cancer.
Patel BJ; Pantuck AJ; Zisman A; Tsui KH; Paik SH; Caliliw R; Sheriff S; Wu L; deKernion JB; Tso CL; Belldegrun AS
J Urol; 2000 Oct; 164(4):1420-5. PubMed ID: 10992426
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts.
Stewart RJ; Panigrahy D; Flynn E; Folkman J
J Urol; 2001 Feb; 165(2):688-93. PubMed ID: 11176459
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).
Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC
Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202
[TBL] [Abstract][Full Text] [Related]
26. Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities.
Montecinos VP; Morales CH; Fischer TH; Burns S; San Francisco IF; Godoy AS; Smith GJ
J Cell Mol Med; 2015 Jul; 19(7):1530-7. PubMed ID: 25736582
[TBL] [Abstract][Full Text] [Related]
27. Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia.
Kwak C; Jin RJ; Lee C; Park MS; Lee SE
BJU Int; 2002 Feb; 89(3):303-9. PubMed ID: 11856116
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration.
Burchardt M; Burchardt T; Chen MW; Hayek OR; Knight C; Shabsigh A; de La Taille A; Buttyan R
Prostate; 2000 May; 43(3):184-94. PubMed ID: 10797493
[TBL] [Abstract][Full Text] [Related]
29. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts.
Levine AC; Liu XH; Greenberg PD; Eliashvili M; Schiff JD; Aaronson SA; Holland JF; Kirschenbaum A
Endocrinology; 1998 Nov; 139(11):4672-8. PubMed ID: 9794479
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.
Mazzucchelli R; Montironi R; Santinelli A; Lucarini G; Pugnaloni A; Biagini G
Prostate; 2000 Sep; 45(1):72-9. PubMed ID: 10960845
[TBL] [Abstract][Full Text] [Related]
31. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
[TBL] [Abstract][Full Text] [Related]
32. Comparison of microscopic vascularity in benign and malignant prostate tissue.
Bigler SA; Deering RE; Brawer MK
Hum Pathol; 1993 Feb; 24(2):220-6. PubMed ID: 8432518
[TBL] [Abstract][Full Text] [Related]
33. RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation.
Rinaldo F; Li J; Wang E; Muders M; Datta K
Oncogene; 2007 Mar; 26(12):1731-8. PubMed ID: 16964283
[TBL] [Abstract][Full Text] [Related]
34. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
35. Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo.
Shibata Y; Kashiwagi B; Arai S; Magari T; Suzuki K; Honma S
Urology; 2006 Nov; 68(5):1127-31. PubMed ID: 17113911
[TBL] [Abstract][Full Text] [Related]
36. Elements regulating angiogenesis and correlative microvessel density in benign hyperplastic and malignant prostate tissue.
Shih SJ; Dall'Era MA; Westphal JR; Yang J; Sweep CG; Gandour-Edwards R; Evans CP
Prostate Cancer Prostatic Dis; 2003; 6(2):131-7. PubMed ID: 12806371
[TBL] [Abstract][Full Text] [Related]
37. Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.
Godoy AS; Chung I; Montecinos VP; Buttyan R; Johnson CS; Smith GJ
Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1131-9. PubMed ID: 23548616
[TBL] [Abstract][Full Text] [Related]
38. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
[TBL] [Abstract][Full Text] [Related]
39. Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition.
Byrne NM; Nesbitt H; Ming L; McKeown SR; Worthington J; McKenna DJ
Br J Cancer; 2016 Mar; 114(6):659-68. PubMed ID: 26954717
[TBL] [Abstract][Full Text] [Related]
40. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.
Doll JA; Reiher FK; Crawford SE; Pins MR; Campbell SC; Bouck NP
Prostate; 2001 Dec; 49(4):293-305. PubMed ID: 11746276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
